Astrazeneca - Свежие новости [ Фото в новостях ] | |
Ethereum Spikes To 2.5 Year Highs As Altcoins Benefit From Bitcoin’s Recent Ascent
Bitcoin is back with a bang. The oldest cryptocurrency surpassed the $18,000 level last week for the first time since the December 2017 rally. On Monday, the cryptocurrency marched higher on reports that the coronavirus vaccine created by the University of Oxford and AstraZeneca can be 90% effective. дальше »
2020-11-25 18:08 | |
AZN Stock Up 1%, AstraZeneca Gets $486M from U.S. for 100K COVID-19 Vaccine Doses
Coinspeaker AZN Stock Up 1%, AstraZeneca Gets $486M from U. S. for 100K COVID-19 Vaccine DosesAlthough the vaccine by AstraZeneca has not been globally approved, it was used in the treatment of U. дальше »
2020-10-12 16:36 | |
AZN Stock Slightly Down, AstraZeneca Resumes Vaccine Trials in Japan, in Talks with U.S. Authorities
Coinspeaker AZN Stock Slightly Down, AstraZeneca Resumes Vaccine Trials in Japan, in Talks with U. S. AuthoritiesAstraZeneca’s clinical trials for the vaccine were halted in July after one of the participants complained of neurological disorder. дальше »
2020-10-2 17:52 | |
AZN Stock Down 0.6%, AstraZeneca Receives Partial Immunity from EU in Vaccine Deal
Coinspeaker AZN Stock Down 0. 6%, AstraZeneca Receives Partial Immunity from EU in Vaccine DealAstraZeneca has received partial immunity from the EU in a vaccine deal. The EU has already paid €336 million at €2. дальше »
2020-9-26 16:46 | |
World Stock Markets Increase as AstraZeneca Resumes Work on Coronavirus Vaccine
Coinspeaker World Stock Markets Increase as AstraZeneca Resumes Work on Coronavirus VaccineStock markets are rallying as AstraZeneca resumes work after a short break in its clinical trials of the COVID-19 vaccine. дальше »
2020-9-15 15:59 | |
Pharmaceutical Giant AstraZeneca Resumes Clinical Trials for COVID-19 Vaccine, AZN Stock Slightly Up
Coinspeaker Pharmaceutical Giant AstraZeneca Resumes Clinical Trials for COVID-19 Vaccine, AZN Stock Slightly UpIn partnership with U. K. 's Oxford University, AstraZeneca said that it will resume the phase three clinical trial for its COVID-19 vaccine contender AZD1222 since it got an approval from UK's Medicines Health Regulatory Authority. дальше »
2020-9-13 12:56 | |
AstraZeneca (AZN) Stock Up Over 2% as Trump Plans to Fast Track AZD1222 Vaccine
Coinspeaker AstraZeneca (AZN) Stock Up Over 2% as Trump Plans to Fast Track AZD1222 VaccineAstraZeneca (AZN) stock up rose by about 4% after the news that President Trump is reportedly ready to give the AZN-Oxford developed AZD1222 vaccine an Emergency Use Authorization Status. дальше »
2020-8-25 18:08 | |
AZN Shows Strong H1 Performance as AstraZeneca Advances COVID-19 Vaccine Clinical Trials
Coinspeaker AZN Shows Strong H1 Performance as AstraZeneca Advances COVID-19 Vaccine Clinical TrialsWith the company's ongoing late-stage clinical trials and its impressive H1 performance results, AstraZeneca (AZN) stock jumped in the pre-market. дальше »
2020-7-30 16:54 | |
AZN Stock Up 2%, AstraZeneca Gets $1B for Oxford University’s Coronavirus Vaccine
Coinspeaker AZN Stock Up 2%, AstraZeneca Gets $1B for Oxford University’s Coronavirus VaccineThe U. S. Biomedical Advanced Research and Development Authority has given AstraZeneca more than $1 billion in funding for the coronavirus vaccine. дальше »
2020-5-21 20:21 | |
AstraZeneca (AZN) Stock Up 3%, Firm Teams Up with Oxford University on Coronavirus Vaccine
Coinspeaker AstraZeneca (AZN) Stock Up 3%, Firm Teams Up with Oxford University on Coronavirus VaccineAs it has become known that AstraZeneca and Oxford University are working together on a coronavirus vaccine, the AZN stock price is rising. дальше »
2020-5-1 18:51 | |